Practical Points from a Residency Clinic. Susan Faragher Bannon, MD, FACP Medical Director Department of Internal Medicine WMU School of Medicine

Size: px
Start display at page:

Download "Practical Points from a Residency Clinic. Susan Faragher Bannon, MD, FACP Medical Director Department of Internal Medicine WMU School of Medicine"

Transcription

1 Practical Points from a Residency Clinic Susan Faragher Bannon, MD, FACP Medical Director Department of Internal Medicine WMU School of Medicine

2 Dr. Bannon has no financial relationships or conflicts of interest to disclose familynews.com

3 WMU School of Medicine Clinics

4

5

6 The Way it Was Prior to our policy in 2003 Staffing resident clinic led to many requests to refill narcotics, especially on Friday afternoons

7 Current Policy Pain contract Drug screens MAPS No refills after hours No medical marijuana First visit policy No replacement of lost/stolen prescriptions

8 In Future? Pill counts Pain clinic? Talk with prior provider if transferring

9 Hope Simple procedures can be implemented to improve tracking and monitoring of chronic narcotic patients, improve quality of care, decrease doctor shopping and improve patient safety. Adherence to our policy helped improve the clinic flow by having everyone following the same rules and making both patients and physicians aware of the expectations and consequences.

10 First Visit Policy New patients to the clinic will not receive narcotics prior to: Assessment being done Old records being obtained/phone call Drug screen being ordered/prelim looked at MAPS report reviewed Controlled substance contract signed

11 Assessment Characteristic Low Risk Moderate Risk High Risk Substance Abuse Never Past Current Smoking (nicotine) Never Past Current FH of Addiction None Significant Significant Psychosocial factors No major diagnoses, minor diagnoses treated or stable Past major diagnoses current issues with minor diagnoses Current major diagnoses untreated or unstable Age Older N/A Younger Hx of Sexual Abuse No N/A Yes Controlled prescriptions lost or stolen Abnormal drug screen No N/A Yes Consistently negative Initially positive Appropriate Use of Opioids in Chronic Pain, Jan 1, 2012 p. 7 Consistently positive

12 Objective To improve appropriate prescribing habits and monitor therapy on potentially dangerous and abusive prescription narcotics, an audit was done of a residency clinic before and after the implementation of a new policy. We now have 60 month data on compliance with this policy as well as follow up on 426 patients that have ever been on pain contract.

13 Research question Does having a narcotic prescribing policy in place improve the narcotic prescribing habits in a residency clinic? What is the long term disposition of patients on pain contract?

14 Methods Protocol was approved by MSU/KCMS research committee/irb Study included 426 adults, who received chronic opioids prescriptions from KCMS (WMED) Internal Medicine and Medicine Pediatrics Clinics between March 2007 and August 2012

15 Methods New procedures were implemented requiring all chronic narcotic patients to have: a controlled substance contract random drug screening a Michigan Automated Prescription System (MAPS) profile on the chart prescriptions and refills all written by same provider if at all possible no narcotics without old records

16 Methods Residents and faculty in clinics were educated of the new policy during preclinic sessions and conference time. The EMR was used to task residents of missing information on their patients. and evaluation sessions were used to reinforce requirements. Chart review and comparison was done before and after implementation of the new policy.

17 Electronic Medical Records Allscripts (old EMR)-patient list was kept and exported to Excel ECW (new EMR)-code is added to problem list to identify them, structured data is used to monitor, and also in Excel Reports of narcotics written are also run Pt calls for refills monitored for narcotics and to ensure they are on the list

18 Inclusion & exclusion criteria All patients receiving chronic narcotic prescriptions from KCMS IM and MP clinics Only adults identified No patients excluded

19 Results Study included patients patients were dismissed after they violated the pain contract (27.4%) [35% at U of M study] 35 patients died (8.2%) 41 patients were dismissed from clinic due to no show (9.6%) 80 patients stopped following with our clinic for various reasons (18.8%) 39 patients were weaned off narcotics successfully and still patients in clinic (9.2%) 113 patients (26.5%) are currently receiving opioids prescriptions from our clinic

20 5 Years of Data Patients 30.00% 25.00% 20.00% 15.00% 10.00% 5.00% Violations-dismissed No Show-Dismissal Deceased Attrition Weaned off Narcotics Current Narcotic Pts 0.00% % as of August 2012

21 Results Pain contract was present on 51% initially and increased to 94.5% of patients after the new procedures were in place (p-value < 0.001) MAPS was present on 11% initially and increased to 92% of patients after the new procedures (p-value < 0.001) Random drug testing was present on 16.3% initially and increased to 91% after the intervention (p-value < 0.001)

22 Results Variable Baseline 3 Months After the Policy Pain contract 40 Months After the Policy 60 Months After the Policy 51% 73% 94.5% 96.3% MAPS 11% 73% 92% 95.3% Random drug testing 16.3% 43.2% 91% 89.7%

23 Policy Compliance % Baseline 3 Months 40 Months 60 Months Pain Contract MAPS Drug Screen

24 Results & Benefits Increase in compliance with the policy Identification of resident educational needs to target education and feedback All patients are treated equally Improve patient safety Decrease doctor shopping Improve job satisfaction Improve clinic flow/decrease phone calls

25 Discussion Labor intensive to continually monitor and track the data Could improved EMR sophistication automatically link narcotic prescription to these requirements? Legal issues: termination of care/report? Interpretation of drug screens

26 Contact Information Susan Bannon Phone: Cell:

Patient Agreement for the use of Opioid Medications

Patient Agreement for the use of Opioid Medications today s date Patient Name date of birth Patient Agreement for the use of Opioid Medications The purpose of this agreement is to give you information about the medications that may be part of your treatment

More information

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this?

Oregon ACEP Opioid Prescribing Guidelines. Why are we talking about this? Oregon ACEP Opioid Prescribing Guidelines Hans Notenboom, M.D. FACEP Current OCEP President Why are we talking about this? Current opioid epidemic 33,000 deaths over half with Rx meds Since 1999 number

More information

Chronic Pain Management with High Dose Opioid Medication

Chronic Pain Management with High Dose Opioid Medication University of Vermont ScholarWorks @ UVM Family Medicine Clerkship Student Projects College of Medicine 2015 Chronic Pain Management with High Dose Opioid Medication Joshua Cohen Follow this and additional

More information

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine Financial Disclosure I have no relevant financial relationships

More information

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin. The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp

More information

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care

Today s Presenters. Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care Pills, Providers, and Problems: How to Investigate Drug Diversion in Long-Term Care 203 - Monday, April 16, 2018 Today s Presenters Ben Purser Former F.B.I. Special Agent Donna Thiel ProviderTrust Chief

More information

INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine

INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine The purpose of this agreement is to give you information about the medications you will be taking for

More information

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Oklahoma Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

MEDICATION MANAGEMENT AGREEMENT

MEDICATION MANAGEMENT AGREEMENT MEDICATION MANAGEMENT AGREEMENT The goal of this agreement is to ensure that you and your physician comply with all state and federal regulations concerning the prescribing of controlled substances. The

More information

Behavioral Health in PACE: Substance Abuse

Behavioral Health in PACE: Substance Abuse Behavioral Health in PACE: Substance Abuse NPA s Quality Symposium 2017 June 9th, 2017 Bharati Srivastava MD MBA FACP AGSF Mercy LIFE Sharon Hill Mercy LIFE Southeastern PA Trinity Health Inc. Objectives

More information

Ahsan U. Rashid, M.D., F.A.C.P.

Ahsan U. Rashid, M.D., F.A.C.P. Ahsan U. Rashid, M.D., F.A.C.P. OPIOID MAINTENANCE AND CONSENT Instructions: Review this document before signing. This document will help both the patient and caregivers in establishing a medical program

More information

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration

Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Teaming Up for Safer Pain Management: Strategies for Effective Collaboration Noah Nesin, MD, FAAFP, Vice President of Medical Affairs, Penobscot Community Health Care Felicity Homsted, PharmD, DPLA, Chief

More information

The Wisconsin Prescription Drug Monitoring Program

The Wisconsin Prescription Drug Monitoring Program The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing

More information

Legal Issues in Opioid Prescribing

Legal Issues in Opioid Prescribing Legal Issues in Opioid Prescribing Joanne L. Martin, J.D. Legal Counsel Mayo Clinic Rochester, Mn 2015 MFMER slide-1 Conflict of Interest I have no relevant financial relationships to disclose I will not

More information

William H. Swiggart, MS

William H. Swiggart, MS William H. Swiggart, MS Co-Director, Center for Professional Health Vanderbilt University Medical Center 2015 All rights reserved. I have no financial relationships to disclose. The purpose of this session

More information

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL DIRECTOR EMERGENCY CARE ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE

More information

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Clinical Safety & Effectiveness Cohort # 11

Clinical Safety & Effectiveness Cohort # 11 Clinical Safety & Effectiveness Cohort # 11 Safety in Opiate Prescribing DATE Educating for Quality Improvement & Patient Safety 1 Financial Disclosure Jane E. O Rorke, M.D, has no relevant financial relationships

More information

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC

EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL D IRECTOR EMERGENCY C A R E ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE

More information

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

On December 27, 2017, the Lieutenant Governor signed into law several new requirements OPIOID Alert MICHIGAN OSTEOPATHIC ASSOCIATION JANUARY 2018 On December 27, 2017, the Lieutenant Governor signed into law several new requirements aimed at combating the opioid epidemic. On the following

More information

OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse

OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse OPIOID ANALGESICS AND STIMULANT MEDICATIONS: A Clinician Guide to Prevent Misuse Advances in pharmacologic therapy have improved quality of life for patients living with pain, ADHD, and other conditions.

More information

PATIENT HISTORY DATA FORM Psychiatric, Health and Wellness, LLC 810 Michael Drive, Suite L Chesterton, IN NAME

PATIENT HISTORY DATA FORM Psychiatric, Health and Wellness, LLC 810 Michael Drive, Suite L Chesterton, IN NAME PATIENT HISTORY DATA FORM Psychiatric, Health and Wellness, LLC 810 Michael Drive, Suite L Chesterton, IN 46304 PRINT THIS FORM, COMPLETE AND BRING WITH YOU (DO NOT COMPLETE ONLINE) : NAME: LAST FIRST

More information

BRENT BELVIN, M.D. NAME: SEX: M F (circle one) DATE OF BIRTH: ADDRESS: CITY: STATE: ZIP:

BRENT BELVIN, M.D. NAME: SEX: M F (circle one) DATE OF BIRTH: ADDRESS: CITY: STATE: ZIP: BRENT BELVIN, M.D. 1101 RAINTREE CIRCLE, SUITE 240 ALLEN, TX 75013 NEW PATIENT INFO CHANGE PATIENT INFORMATION NAME: SEX: M F (circle one) DATE OF BIRTH: ADDRESS: CITY: STATE: ZIP: HOME PHONE: WORK: CELL:

More information

PATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone

PATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone PATIENT INTAKE: MEDICAL HISTORY Name Address Phone (W) (H) (C) DOB Age SS# Emergency Contact Relationship to patient Phone Primary care physician Phone Have you ever had an EKG? Y N Date Current or past

More information

Welcome to the second module of the Screening, Brief Intervention, and Referral to Treatment Core Curriculum. In this module, we ll address screening

Welcome to the second module of the Screening, Brief Intervention, and Referral to Treatment Core Curriculum. In this module, we ll address screening Welcome to the second module of the Screening, Brief Intervention, and Referral to Treatment Core Curriculum. In this module, we ll address screening patients for substance use in a clinical setting. 1

More information

CALIFORNIA PAIN MEDICINE CENTERS New Patient History and Intake Form

CALIFORNIA PAIN MEDICINE CENTERS New Patient History and Intake Form CALIFORNIA PAIN MEDICINE CENTERS New Patient History and Intake Form Date: Name: _ Age: Sex: Occupation: 1. Who referred you? 2. What is your primary complaint? PCP: Referring Specialist: How long have

More information

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use

Effective Date: May 19, Revised Date: August 18, Policy Number: MED Policy 313. Pain Management Long Term Opioid Use Effective Date: May 19, 2008 Revised Date: August 18, 2015 Approved by: Thomas M Tocher, MD, MPH, Chief Clinical Officer Policy Number: MED Policy 313 Title: Pain Management Long Term Opioid Use POLICY

More information

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / /

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / / COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION Name Birthdate / / Home phone ( ) - Cell phone ( ) - Please answer the following questions which will help

More information

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System

Reducing Opioid Over- Prescribing in a Large Integrated Health Care System Session L6 This presenter has nothing to disclose It Takes a Village to Curb the Prescription Opioid Epidemic: Reducing Opioid Over- Prescribing in a Large Integrated Health Care System Joel D. Hyatt,

More information

Patient Application for Treatment

Patient Application for Treatment Address: 179 Linwood Ave. Colchester, CT 06415 Phone: (860) 603-3541 Fax: (860) 603-3544 Visit Date: / / MR#: Patient Application for Treatment 1. Name: 2. Date of Birth: 3. Social Security #: 2. Address:

More information

POLICIES AND PROCEDURES. Lead Department/Committee: (Refer also to GFHS Narcotic Treatment Protocols) Statement of Need

POLICIES AND PROCEDURES. Lead Department/Committee: (Refer also to GFHS Narcotic Treatment Protocols) Statement of Need 1 POLICIES AND PROCEDURES Lead Department/Committee: Behavioral Health Title: Long Term Narcotic Treatment with Opiate Pain Meds, Stimulants, and/or Benzodiazepines Original Date: 08/01/2013 Last Revision

More information

ASPMN Conference Baltimore, Maryland

ASPMN Conference Baltimore, Maryland ASPMN Conference Baltimore, Maryland Prescribing Controlled Substances Managing Risk and Optimizing Outcomes September 13, 2012 Tracey Fremd, NP Tracey Fremd Consulting, Inc. Most Common Uses for Controlled

More information

Prescription Drug Safety for Teens

Prescription Drug Safety for Teens Prescription Drug Safety for Teens Curriculum Guide Recommended Grade Level 9-12 Total Time 30-45 minutes Subject Fit Health Standards Alignment National Health Education Standards (NHES) With prescription

More information

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update

4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov

More information

Utah. Prescribing and Dispensing Profile. Research current through November 2015.

Utah. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Utah Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view

More information

Recovery Coaching Support Tool

Recovery Coaching Support Tool Recovery Coaching Support Tool Date / / We appreciate that recovery coaching is a collaborative process between two people who are committed to recovery. We hope that both participants will be willing

More information

Workplace Substance Abuse

Workplace Substance Abuse Workplace Substance Abuse William F. Badzmierowski, M.ED., CSW June 18, 2015 Objectives Participation in this Prepare Training Presentation will empower participants to: Describe the prevalence, progression,

More information

I HAVE READ THE ABOVE AND AGREE TO THE TERMS.

I HAVE READ THE ABOVE AND AGREE TO THE TERMS. DATE: / / LAST NAME: FIRST NAME: DOB: / / AGE: GENDER: M F STREET ADDRESS: CITY/STATE/ZIP: HOME PHONE: CELL: WORK: EMAIL: PREFERRED CONTACT METHOD: SSN: - - RACE: LANGUAGE: EMERGENCY CONTACT/RELATIONSHIP

More information

Green Dragon Temple / Green Gulch Farm Zen Center FALL PRACTICE PERIOD APPLICATION October 17 December 12, 2017

Green Dragon Temple / Green Gulch Farm Zen Center FALL PRACTICE PERIOD APPLICATION October 17 December 12, 2017 Green Dragon Temple / Green Gulch Farm Zen Center FALL PRACTICE PERIOD APPLICATION October 17 December 12, 2017 Name Date Age D.O.B. Address City State Zip Country Phone Alternate Phone E-mail Please put

More information

For female patients only: To the best of my knowledgei am NOT pregnant. Patients Initials:

For female patients only: To the best of my knowledgei am NOT pregnant. Patients Initials: Which doctor are you here to see? NAME OF PATIENT: DATE: TO THE PATIENT: As a patient, you have the right to be informed about your condition and the recommended medical or diagnostic procedure or drug

More information

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE Valerie Carrejo, MD Assistant Professor UNM Family Medicine Advances in Primary Care April 14, 2017 Objectives Review the basic

More information

Acupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians

Acupuncture. Opioid Prescribing: Pitfalls for Occupational Medicine Physicians Opioid Prescribing: Pitfalls for Occupational Medicine Physicians Presented by Scott Levy M.D. M.P.H. FACOEM Assistant Regional Medical Director, Occupational Health Services The Permanente Medical Group

More information

PATIENT SIGNATURE: DOB: Date:

PATIENT SIGNATURE: DOB: Date: CINCINNATI PAIN PHYSICIANS, LLC (CPP) ACKNOWLEDGEMENT OF RECEIPT OF NOTICE OF PRIVACY PRACTICES By signing below, I acknowledge that I have received a copy of CPP s Notice of Privacy Practices. The Notice

More information

RED FLAGS, SCREENING AND DIAGNOSING OUD IN CHRONIC PAIN PATIENTS DR. PAULA COOK & DR. ELIZABETH HOWELL

RED FLAGS, SCREENING AND DIAGNOSING OUD IN CHRONIC PAIN PATIENTS DR. PAULA COOK & DR. ELIZABETH HOWELL RED FLAGS, SCREENING AND DIAGNOSING OUD IN CHRONIC PAIN PATIENTS DR. PAULA COOK & DR. ELIZABETH HOWELL OBJECTIVES A look at chronic pain and opioid therapy Screening for opioid use disorder (OUD) in chronic

More information

The Changing Landscape of Opioids & Workers Compensation. Presented by: David Campbell, MA, CRC State of Michigan Workers Compensation Agency

The Changing Landscape of Opioids & Workers Compensation. Presented by: David Campbell, MA, CRC State of Michigan Workers Compensation Agency The Changing Landscape of Opioids & Workers Compensation Presented by: David Campbell, MA, CRC State of Michigan Workers Compensation Agency 1 The Changing Landscape of Opioids & Workers Compensation is

More information

Syracuse Community Treatment Court. Handbook for Participants. Guidelines and Program Information

Syracuse Community Treatment Court. Handbook for Participants. Guidelines and Program Information Syracuse Community Treatment Court Handbook for Participants Guidelines and Program Information John C. Dillon Public Safety Building 511 South State Street Room 117 Syracuse, New York 13202 PHONE 315-671-2795

More information

Opioid Pain Contracts: A Resident Driven Quality Improvement Project

Opioid Pain Contracts: A Resident Driven Quality Improvement Project Opioid Pain Contracts: A Resident Driven Quality Improvement Project A Response to the Opioid Epidemic Dr. Phillip Knouse Dr. Victoria Montgomery Disclosure None Objectives Discuss the current Opioid Epidemic

More information

NOW CANADA SOCIETY TUTT STREET KELOWNA, BC V1Y 8Z5 TELEPHONE (250) FAX (250)

NOW CANADA SOCIETY TUTT STREET KELOWNA, BC V1Y 8Z5 TELEPHONE (250) FAX (250) NOW CANADA SOCIETY 2970 TUTT STREET KELOWNA, BC V1Y 8Z5 TELEPHONE (250) 763-3876 FAX (250) 868-3876 EMAIL support@nowcanada.ca RESIDENTIAL / DAY PROGRAM REFERRAL PACKAGE THE NOW CANADA SOCIETY MISSION

More information

CU Recreation Center

CU Recreation Center CU Recreation Center Personal Training Congratulations on your decision to invest in yourself! Our qualified, nationally certified personal trainers will provide you with the right information and right

More information

Objective: 9.ATOD.1.5 Predict the effects of substance abuse on other people as well as society as a whole

Objective: 9.ATOD.1.5 Predict the effects of substance abuse on other people as well as society as a whole Objective: 9.ATOD.1.5 Predict the effects of substance abuse on other people as well as society as a whole Scholar What do you consider substance abuse and why? Smoking marijuana is a form of substance

More information

19 TH JUDICIAL DUI COURT REFERRAL INFORMATION

19 TH JUDICIAL DUI COURT REFERRAL INFORMATION 19 TH JUDICIAL DUI COURT REFERRAL INFORMATION Please review the attached DUI Court contract and Release of Information. ******* You must sign and hand back to the court the Release of Information today.

More information

Controlled Substance and Wellness Agreement

Controlled Substance and Wellness Agreement Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)

More information

Tracker e-prescribing 101. The Complete Guide

Tracker e-prescribing 101. The Complete Guide Tracker e-prescribing 101. The Complete Guide Copyright Stratum Access Technologies, Inc. 2017 www.stratumaccess.com Electronic prescribing, known in short as e-prescribing, is a method of prescription

More information

Medication Assisted Treatment

Medication Assisted Treatment Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,

More information

Last Name First Middle Date of Birth Age. Residence Address City State Zip Code

Last Name First Middle Date of Birth Age. Residence Address City State Zip Code The following necessary information will help make your first session most productive. Please PRINT and fill out this form COMPLETELY. DEMOGRAPHICS Date: Last Name First Middle Date of Birth Age Residence

More information

Member Assistance Program S TRONGER TOG ETHER. Local 338 RWDSU / UFCW

Member Assistance Program S TRONGER TOG ETHER.   Local 338 RWDSU / UFCW Local 338 RWDSU / UFCW Member Assistance Program Authored By: Charles Hamilton, Funds Administrator Jennifer Lipack, MAP Director www.local338.org facebook.com/local338 twitter.com/local338 Local 338 RWDSU/UFCW

More information

Medication Agreements Promoting awareness, dialogue and level-set expectations

Medication Agreements Promoting awareness, dialogue and level-set expectations Medication Agreements Promoting awareness, dialogue and level-set expectations A young man had his leg amputated following a work-related injury. His pain doctor, by all accounts, was trying to responsibly

More information

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain

Missouri Guidelines for the Use of Controlled Substances for the Treatment of Pain Substances for the Treatment of Pain Effective January 2007, the Board of Healing Arts appointed a Task Force to review the current statutes, rules and guidelines regarding the treatment of pain. This

More information

ACAMH Malta Addictions in Adolescents Conference

ACAMH Malta Addictions in Adolescents Conference Deadline for abstract submission is Monday 17 July 2017 Addictions in Adolescents Conference Friday 13 October 2017 Call for Abstracts We welcome abstracts from interested professionals who would like

More information

ROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE

ROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE ROLE PLAY #1: ASSESSMENT WITH THE 6 A s PATIENT ROLE You are a 58 year old man/woman and have a history of severe chronic low back pain for 20 years. You injured your back 20 years ago at work and have

More information

We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit

We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit We are not the Boogeyman! Detective A. McMillan Prince William County Police Narcotics Unit Objectives Provide a background of the law enforcement initiative with the current heroin problem and how we

More information

Evidence of Effectiveness. Pathways To Safer Opioid Use. willinteractive.com PHONE (301) FAX (301)

Evidence of Effectiveness. Pathways To Safer Opioid Use. willinteractive.com PHONE (301) FAX (301) Evidence of Effectiveness Pathways To Safer Opioid Use willinteractive.com PHONE (301) 983 6006 FAX (301) 983 6008 10000 Falls Road, Suite 305 Potomac, MD 20854 Preface This document contains selected

More information

Screening for Potential Prescription Opioid Misuse in a Michigan Medicaid Population

Screening for Potential Prescription Opioid Misuse in a Michigan Medicaid Population Clinical Research and Methods Vol. 41, No. 10 729 Screening for Potential Prescription Opioid Misuse in a Michigan Medicaid Population Laurie S. Braker, MD; Anna E. Reese, MD; Randall O. Card, MD; Robert

More information

Prescription Monitoring Program (PMP)

Prescription Monitoring Program (PMP) 06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid

More information

Application for House Membership

Application for House Membership Application for House Membership Name: Date of Birth: Age: Phone: (h) (c) (w) Email: Current or Mailing Address: Are you currently homeless/without a permanent place to live? Yes No Most recent address

More information

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998

KANSAS Kansas State Board of Healing Arts. Source: Kansas State Board of Healing Arts. Approved: October 17, 1998 KANSAS Kansas State Board of Healing Arts Source: Kansas State Board of Healing Arts Approved: October 17, 1998 GUIDELINES FOR THE USE OF CONTROLLED SUBSTANCES FOR THE TREATMENT OF PAIN Section 1: Preamble

More information

Crossroads for Women Application

Crossroads for Women Application Crossroads for Women Application Application Instructions Please check the box next to the program you are applying to: The Crossroads Albuquerque, NM (must have history of homelessness) Hope House Albuquerque,

More information

Colorado State Board of Medical Examiners Policy

Colorado State Board of Medical Examiners Policy POLICY NUMBER: 10-14 Title: Guidelines for the Use of Controlled Substances for the Treatment of Pain Date Issued: May 16, 1996 Date(s) Revised: November 18, 2004 Reference: 12-36-117, C.R.S. Purpose:

More information

9/9/2016. Drug Name (select from list of drugs shown) Bunavail Buccal Film (buprenorphinenaloxone) Suboxone Sublingual Film (buprenorphine-naloxone)

9/9/2016. Drug Name (select from list of drugs shown) Bunavail Buccal Film (buprenorphinenaloxone) Suboxone Sublingual Film (buprenorphine-naloxone) 9/9/2016 Prior Authorization Form PASSPORT HEALTH PLAN KENTUCKY MEDICAID Buprenorphine Products This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,

More information

Transitional Care for HIV and AIDS from Adolescence to Adulthood

Transitional Care for HIV and AIDS from Adolescence to Adulthood Transitional Care for HIV and AIDS from Adolescence to Adulthood October 2011 Featured Speaker Conflict of Interest Statement Jeffrey M. Birnbaum, MD, MPH Associate Professor of Pediatrics and Public Health,

More information

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Vermont. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Vermont Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points of

More information

Medication Assisted Treatment Conference

Medication Assisted Treatment Conference Medication Assisted Treatment Conference starting a common conversation WHEN: September 8-10 9:00am 4:00pm You are invited to attend a 3-day / 2-part training event, September 8-10, introducing best practices

More information

XV. DRUG-FREE WORKPLACE PROCEDURES XV-1

XV. DRUG-FREE WORKPLACE PROCEDURES XV-1 XV. DRUG-FREE WORKPLACE PROCEDURES XV-1 THIS PAGE HAS BEEN LEFT INTENTIONALLY BLANK XV-2 DRUG-FREE WORKPLACE GENERAL POLICY STATEMENT 6Gx13-4-1.05 The School Board of Miami-Dade County, Florida recognizes

More information

Vermont Recovery Network

Vermont Recovery Network Vermont Recovery Network 200 Olcott Drive White River Junction, VT 05001 vtrecoverynetwork@gmail.com www.vtrecoverynetwork.org 802-738-8998 The Vermont Recovery Network currently consists of 12 recovery

More information

1 Department of Family Medicine 2 Department of Preventive Medicine and Public Health

1 Department of Family Medicine 2 Department of Preventive Medicine and Public Health : Residents Attitudes and Behavior toward Managing Patients on Chronic Opiate Therapy Jana K. Zaudke, M.D., M.A. 1, Edward F. Ellerbeck, M.D., M.P.H. 2 University of Kansas Medical Center, School of Medicine-Kansas

More information

Patient Information Form

Patient Information Form Patient Information Form Patient Name: (Last) (First) (MI) Name you prefer to be called: Mailing address: City: State: Zip: Best daytime phone: May we leave a message there? Yes No Alternate phone number:

More information

Using Screening, Brief Intervention & Referral to Treatment (SBIRT) in Practice: A Skills Building Workshop

Using Screening, Brief Intervention & Referral to Treatment (SBIRT) in Practice: A Skills Building Workshop Using Screening, Brief Intervention & Referral to Treatment (SBIRT) in Practice: A Skills Building Workshop Joanne DeSanto Iennaco PhD, PMHNP BC, PMHCNS BC, APRN Acknowledgements Yale SBIRT Medical Health

More information

Michigan Legislative and Regulatory Pharmacy Initiatives Update

Michigan Legislative and Regulatory Pharmacy Initiatives Update Michigan Legislative and Regulatory Pharmacy Initiatives Update Michigan Association of Health Plans Summer Conference Carrie Germain, R.Ph. Health Alliance Plan Senior Director, Pharmacy, Quality and

More information

Basic Standards for Fellowship Training in Addiction Medicine

Basic Standards for Fellowship Training in Addiction Medicine Basic Standards for Fellowship Training in Addiction Medicine American Osteopathic Association and American College of Osteopathic Family Physicians American College of Osteopathic Internists American

More information

SUBSTANCE ABUSE UNIT UNIT PACKET NAME: PERIOD: SCORE:

SUBSTANCE ABUSE UNIT UNIT PACKET NAME: PERIOD: SCORE: SUBSTANCE ABUSE UNIT UNIT PACKET NAME: PERIOD: SCORE: _ \ SUBSTANCE ABUSE OVERVIEW IN-CLASS PROJECT DIRECTIONS: You will be working with your classmates to gather information about Substance Abuse. During

More information

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015.

Louisiana. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile Louisiana Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

ECHO: Healthy Alternatives for Pain Management. and AB 474 Compliance Check lists

ECHO: Healthy Alternatives for Pain Management. and AB 474 Compliance Check lists ECHO: Healthy Alternatives for Pain Management and AB 474 Compliance Check lists BEFORE I CAN WRITE AN INITIAL PRESCRIPTION Have I established a bona fide relationship with the patient? Have I established

More information

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women

An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women An Adaptive Reinforcement-Based Treatment (RBT) Intervention for Pregnant Substance Dependent Women Michelle Tuten, Ph.D. Assistant Professor Department of Psychiatry and Behavioral Sciences and Johns

More information

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

West Virginia. Prescribing and Dispensing Profile. Research current through November 2015. Prescribing and Dispensing Profile West Virginia Research current through November 2015. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug Control Policy. Points

More information

Opioid Stewardship Davies Presentation

Opioid Stewardship Davies Presentation Opioid Stewardship Davies Presentation Todd Burstain, MD CMIO Ochsner Health Systems Deborah Simonson, Pharm D. Vice President, Pharmacy Ochsner Health Systems Richard Guthrie, MD Chief Quality Officer

More information

Top 10 narcotic pain pills

Top 10 narcotic pain pills Top 10 narcotic pain pills Click to go to the item or just scroll down the page. Doctors Respond to FDA Panel Recommendations FDA Considers Banning Popular Prescription Pain Medications and. Top 10 Natural

More information

OFFICIAL POLICY. Policy Statement

OFFICIAL POLICY. Policy Statement OFFICIAL POLICY 9.1.6 Employee Drug and Alcohol Abuse Policy 2/8/16 Policy Statement Employee Drug and Alcohol Abuse Policy #CofC.HR.DA.03 Revised 12/2001 The Drug-Free Schools and Communities Act The

More information

APPLICATION FOR ADMISSION (PLEASE PRINT CLEARLY)

APPLICATION FOR ADMISSION (PLEASE PRINT CLEARLY) 1317 w. Washington Blvd. Fort Wayne, In. 46802 260-424-2341 APPLICATION FOR ADMISSION (PLEASE PRINT CLEARLY) NAME: _ FIRST MI LAST DATE OF BIRTH: / / AGE: SOCIAL SECURITY NUMBER: LAST OR CURRENT ADDRESS:

More information

Having the Courage to Change. Program Application. A ministry of City Gospel Mission. SS# Driver s License # City State ZIP

Having the Courage to Change. Program Application. A ministry of City Gospel Mission. SS# Driver s License # City State ZIP Having the Courage to Change A ministry of City Gospel Mission Program Application Date: Prison ID#: GENERAL INFORMATION Personal Information Name Aliases Race/Ethnicity Date of Birth SS# Driver s License

More information

COLUMBUS PSYCHOLOGICAL ASSOCIATES, L.L.P.

COLUMBUS PSYCHOLOGICAL ASSOCIATES, L.L.P. COLUMBUS PSYCHOLOGICAL ASSOCIATES, L.L.P. 2325 BROOKSTONE CENTRE PARKWAY / COLUMBUS, GA 31904 PHONE: (706) 653-6841 FAX: (706) 653-7843 Adult Outpatient Psychosocial History Psychosocial Self-Assessment

More information

Name Age PLEASE INDICATE YOUR PRIMARY PHYSICIAN (PCP): PHYSICIAN S NAME: OFFICE ADDRESS: SPECIALITY: PHONE #:

Name Age PLEASE INDICATE YOUR PRIMARY PHYSICIAN (PCP): PHYSICIAN S NAME: OFFICE ADDRESS: SPECIALITY: PHONE #: Name Age PLEASE INDICATE YOUR PRIMARY PHYSICIAN (PCP): PHYSICIAN S NAME: OFFICE ADDRESS: SPECIALITY: PHONE #: PLEASE INDICATE ANY PHYSICIAN S THAT HAS TREATED YOUR CONDITION: EX: HOSPITAL, URGENT CARE,

More information

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Jeanette M. Tetrault, MD FACP FASAM Associate Professor of Medicine Program

More information

Aging and Addiction:

Aging and Addiction: Aging and Addiction: How C.U.R.E.S. and other modalities can Assist in Addressing Addiction in Older Adults VCMC CME Series Celia Woods, M.D., VCBH Mike Small, DOJ CURES Administrator April 30, 2014 Learning

More information

Wisconsin Opioid Prescribing Guideline Draft Scope and purpose of the guideline

Wisconsin Opioid Prescribing Guideline Draft Scope and purpose of the guideline Wisconsin Opioid Prescribing Guideline Draft Scope and purpose of the guideline: To help providers make informed decisions about acute and chronic pain treatment -pain lasting longer than three months

More information

The role of behavioral interventions in buprenorphine treatment of opioid use disorders

The role of behavioral interventions in buprenorphine treatment of opioid use disorders The role of behavioral interventions in buprenorphine treatment of opioid use disorders Roger D. Weiss, MD Harvard Medical School, Boston, MA, McLean Hospital, Belmont, MA, USA Today s talk Review of studies

More information

Elana Klemm, LPC, NCC Compassionate Care Counseling 4343 Shallowford Rd. Suite H-1B Marietta, GA ( ) NEW CLIENT INFORMATION

Elana Klemm, LPC, NCC Compassionate Care Counseling 4343 Shallowford Rd. Suite H-1B Marietta, GA ( ) NEW CLIENT INFORMATION Elana Klemm, LPC, NCC Compassionate Care Counseling 4343 Shallowford Rd. Suite H-1B Marietta, GA. 30062 (404 783-7086) NEW CLIENT INFORMATION Last Name of Client First Name Middle Initial Social Security

More information

Use of Opioids for Chronic Non Malignant Pain (CNMP)

Use of Opioids for Chronic Non Malignant Pain (CNMP) I. PURPOSE Use of Opioids for Chronic Non Malignant Pain (CNMP) We the Safe Opioid Prescribing and Review Committee (SOPARC) are inspired to support a shift in opioid prescribing that improves clinical

More information

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.

Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation. Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education

More information

Does nyquil have codeine

Does nyquil have codeine P ford residence southampton, ny Does nyquil have codeine Among all non-prescription sleep aids, chamomile is one of the most popular. But does the research really support this? I have had the crap that

More information

Understanding Addiction

Understanding Addiction Understanding Addiction How Addiction Hijacks the Brain Addiction involves craving for something intensely, loss of control over its use, and continuing involvement with it despite adverse consequences.

More information